Multi-morbidity Screening in People With Type 2 Diabetes and Pre Diabetes
NCT ID: NCT06053177
Last Updated: 2025-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
400 participants
OBSERVATIONAL
2023-01-25
2028-02-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to pilot a new style of clinic to address these issues. The investigators will perform a multi-morbidity assessment, where they will look for several different health problems at the same time. The investigators will be looking at health problems linked with high blood sugars, this will include problems with the liver, heart, nerves, eyes, and participants breathing overnight. They have developed a clinic visit which uses questionnaires, simple examination techniques and modern devices to try and identify these health problems.
An important part of healthcare is the burden it places on people with health problems, with this in mind the investigators will be giving the people involved in their study a voice to try and direct future research and healthcare, the investigators will ask them to provide feedback on their experience in taking part in the study and what their thoughts are in undergoing a longer but more comprehensive health appointment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening and Understanding of the Pre-diabetes: DECODIAB
NCT01739868
A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 Diabetes
NCT00318032
Diabetes Diagnosis During Acute Admissions (FIND-IT)
NCT04653545
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
NCT03132129
Metabolic Syndrome and Prediabetes
NCT07243821
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Type 2 Diabetes
Participants with type 2 diabetes
No interventions assigned to this group
Pre Diabetes
Participants who's most recent HbA1c is in the prediabetes range.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants with a documented diagnosis of type 2 diabetes or HbA1c ≥48mmol/mol.
* Age ≥18 years
Prediabetes study group
* HbA1c 42 - 47 mmol/mol (inclusive) or enrolled in the diabetes prevention programme.
* Age ≥18 years
Exclusion Criteria
* Participants who are pregnant at the time of screening
* Unable to give informed consent
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liverpool
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Uazman Alam, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Liverpool
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Science Centre, Aintree University Hospital
Liverpool, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UoL001691
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.